Autologous Stem Cell Harvesting for Waldenstrom's Macroglobulinemia
- Harvest and store adequate CD34+ stem cells from patients with Waldenstrom's
macroglobulinemia (WM) for potential future use in transplantation strategies.
- Evaluate the ability to harvest stem cells after therapy for WM (e.g.,
fludarabine-based chemotherapy) by evaluating the number of days to adequate harvest.
- Collect aliquots of stem cells for future research analysis as part of a WM database
OUTLINE: Patients undergo collection of autologous stem cells beginning on day 4 or 5 and
continuing until an adequate number of stem cells are collected. Cells are then
PROJECTED ACCRUAL: A total of 40 patients will be accrued for this study.
Number of days to adequate stem cell harvest
Gwen L. Nichols, MD
Herbert Irving Comprehensive Cancer Center
|Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center||New York, New York 10032|